1Rogaski MA,Portor RJ. Antiopiloptic drugs: pharmacological- mechanisms and clinical efficacy with consideration of promising developmental stage eompounds[J]. Pharmaeol Rev, 1990, 42(3) :2 231.
2Armijo JA,Shushtarian M,Valdizan EM,et al. Ion channel and epilepsy[J]. Curr Pharm Des, 2005, 11(15) :1 975-2 003.
3Spadoni F, Hainsworth AH, Mercuri NB, et al. Lamotrigine derivatives and riluzole inhibite Ina,P in cortical nuurons [J]. Neuroreport, 2002, 13(9):1 167-1 170.
4McDonald DG, Najan Y,Keegan MB. The use of lamotrigine, vigabatrin and gabapentin as add on therapy in intractable epilepsy of childhood[J]. Neuroreport, 2005, 20(2): 25-34.
5Kilie H, Ekici B, Ergul Y, et al. Lamotrigine-induced SIADH in a child with central diabetes insipidus[J]. J Pediatr Neurosci, 2011, 6(1):89-90.
6Marson AG, Alkharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin,lamotrigihe, oxearbazepine, or topiramatc for treatment of partial epilepsy: an unblinded randomised controlled trial[J]. Lancet, 2007, 369(9 566): 1 000-1 015.
8Bullman J, Nieholls A, Van Landingham K, et al. Effects of lamotfigine and phenytoin on the phm'maeokinetics of atorvastatin in healthy volunteers[J]. Epilepsia, 2011, 52(7) : 1 351-1 358.
9Mervaala E, Koivista K, Hanninen T,et al. Eletrophysiological and neuropsyehologieal profiles of lamotrigine in young and age-associated memory impairment subjects[J]. Neurology, 1995, 45 (Suppl 4):A259.
10Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs andcognitive jssues[J]. Epilepsia, 2003, 44(Suppl 4) : 21-29.
二级参考文献20
1Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults : expert opinion, 2005. Epilepsy Behav, 2005, 7 Suppl 1 : S1-64.
2French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I. Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2004, 62: 1252-1260.
3Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia, 1998, 39 : 5-17.
4Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med, 2000, 342: 314-319.
5Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet, 2007, 369 : 1016-1026.
6Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus ahernative monotherapy in patients with partial epilepsy failing on a single drug: a muhicentre, randomized, pragmatic controlled trial. Epilepsy Res, 2003, 57: 1-13.
7Kwan P, Brodie MJ. Epilepsy after the first drug fails : substitution or add-on? Seizure, 2000, 9: 464468.
8Hauser WA. Seizure disorders: the changes with age. Epilepsia, 1992, 33 Suppl 4: $6-14.
9Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet, 1998, 352: 1970-1973.
10Faught E. Monotherapy in adults and elderly persons. Neurology, 2007, 69 (24 Suppl 3 ) : $3-$9.
